Compare BEAM & VTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BEAM | VTMX |
|---|---|---|
| Founded | 2017 | 1998 |
| Country | United States | Mexico |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.4B |
| IPO Year | 2020 | 2023 |
| Metric | BEAM | VTMX |
|---|---|---|
| Price | $31.65 | $32.01 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 3 |
| Target Price | ★ $46.00 | $30.50 |
| AVG Volume (30 Days) | ★ 2.0M | 60.3K |
| Earning Date | 02-24-2026 | 02-19-2026 |
| Dividend Yield | N/A | ★ 2.17% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.07 |
| Revenue | $55,701,000.00 | ★ $271,805,969.00 |
| Revenue This Year | N/A | $13.43 |
| Revenue Next Year | $26.52 | $9.87 |
| P/E Ratio | ★ N/A | $45.07 |
| Revenue Growth | N/A | ★ 11.74 |
| 52 Week Low | $13.53 | $21.30 |
| 52 Week High | $36.44 | $32.51 |
| Indicator | BEAM | VTMX |
|---|---|---|
| Relative Strength Index (RSI) | 56.44 | 57.91 |
| Support Level | $29.80 | $31.70 |
| Resistance Level | $35.34 | $32.45 |
| Average True Range (ATR) | 2.80 | 0.59 |
| MACD | 0.14 | 0.04 |
| Stochastic Oscillator | 55.79 | 78.05 |
Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.
Corporacion Inmobiliaria Vesta SAB de CV is an internally managed real estate company that owns, manages, develops, and leases industrial properties in Mexico. The Company's primary business is the acquisition, development, and management of industrial and distribution center real estate. The company designs and constructs park-to-suit projects across various industries; undertakes build-to-suit projects; and provides site selection, design and engineering, and sale and leaseback services. The primary source of revenue is the rental income received from customers under operating leases. It serves aerospace, automotive, food and beverage, logistics, medical devices, plastics, and other industries.